Patent No. Australia 23244/88 Issued 632,462 Austria EP 88907510.7 Granted EP/0371998 Belgium EP 88907510.7 Granted EP/0371998 Canada 572,398 Pending Denmark 192/90 Pending Europe EP 88907510.7 Granted EP/0371998 Europe EP 95119798.7 Granted EP/0731167 France EP 88907510.7 Granted EP/0371998 Germany EP 88907510.7 Granted EP/0371998 Italy EP 88907510.7 Granted EP/0371998 Japan 506481/88 Xxxxxxx 2991720 Luxembourg EP 88907510.7 Granted EP/0371998 Netherlands EP 88907510.7 Granted EP/0371998 Sweden EP 88907510.7 Granted EP/0371998 Switzerland/ Liechtenstein EP 88907510.7 Granted EP/0371998 United Kingdom EP 88907510.7 Granted EP/0371998 Europe EP 93100041.8 Granted EP/0550400 -1-
Patent No. Germany EP 88907510.7 Granted EP/0371998 Italy EP 88907510.7 Granted EP/0000000 Japan 506481/88 Granted 2991720 Luxembourg EP 88907510.7 Granted EP/0371998 Netherlands EP 88907510.7 Granted EP/0371998 Sweden EP 88907510.7 Granted EP/0371998 Switzerland/Liechtenstein EP 88907510.7 Granted EP/0371998 United Kingdom EP 88907510.7 Granted EP/0371998 COUNTRY SERIAL NO. PATENT NO. Europe EP 93100041.8 Granted EP/0550400 Austria EP 93100041.8 Granted EP/0550400 Belgium EP 93100041.8 Granted EP/0550400 France EP 93100041.8 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Luxembourg EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 *United States 07/077,528 111 of 124 ***Confidential Treatment Requested 3) Based on U.S. Serial No. 07/501,092 filed March 29, 1990, which is a continuation-in-part of U.S. Serial No. 07/077,528 (Modular Assembly of Antibody Genes, Antibodies Prepared Thereby and Use; Robinson, Liu, Horwitz, Wall, Better) and of U.S. Serial No. 07/142,039 (Novel Plasmid Vector with Pectate Lyase Signal Sequence; Lei, Xxxxxx). COUNTRY SERIAL NO. PATENT NO. *United States 07/501,092 *United States 07/987,555 *United States 07/870,404 *United States 08/020,671 United States 08/235,225 5,618,920 United States 08/299,085 5,595,898 United States 08/357,234 5,576,195 United States 08/472,696 5,846,818 United States 08/472,691 6,204,023 United States 08/467,140 5,698,435 United States 08/450,731 5,693,493 United States 08/466,203 5,698,417 * Cases abandoned in favor of a continuing application. 112 of 124 ***Confidential Treatment Requested Schedule 2.4 Form of Notice XOMA owns a number of patents covering various aspects of bacterial antibody expression and phage display. XOMA has licensed these patents on a non-exclusive basis to MORPHOSYS. Under the license agreement with XOMA: 🌑 MORPHOSYS cannot provide phage display services or transfer phage display materials, products or information to you without first showing you a redacted copy of its license from XOMA and this notice. 🌑 If you and MORPHOSYS enter into a written agreement by which you become a ‘MORPHOSYS collaborator’, then you will be permitted to use MORPHOSYS phage display services, MORPHOSYS phage display materials, products and information to research, develop and commercia...
Patent No. United States 06/793,980 Australia 65981/86 Issued 606,320 Canada 521,909 Abandoned Denmark 3385/87 Pending Taiwan 75105650 Issued 51922 *United States U.S. National Phase of PCT/US86/02269
Patent No. EXPIRES [***] [***] [***] [***] [***]
Patent No. United States 06/793,980 Australia 65981/86 Issued 606,320 Canada 521,909 Abandoned Denmark 3385/87 Pending Taiwan 75105650 Issued 51922 *United States 06/086,266 2) Based on PCT/US88/02514, which corresponds to U.S. Serial No. 07/077,528, which is a continuation-in-part of 06/086,266 (abandoned), which is a continuation-in-part of U.S. Serial No. 06/793,980 (abandoned).
Patent No. Issue Date Invention Inventor ---------- ---------- --------- --------
Patent No. Europe EP 93100041.8 Granted EP/0550400 Austria EP 93100041.8 Granted EP/0550400 Belgium EP 93100041.8 Granted EP/0550400 France EP 93100041.8 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Luxembourg EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 *United States 07/077,528
Patent No. Issue Date Title -------- ---------- ---------- -----
Patent No. TITLE ---------- ---------- ----- 10/339996 n/a METHOD AND APPARATUS FOR ESTABLISHING AND MAINTINING VOICE COMMUNICATIONS AMONG A COMMUNITY OF INTEREST 10/341211 n/a A HARDWARE-ASSISTED TUPLE SPACE 10/368667 n/a REMOTE PROGRAMMING OF SERIALIZED SEMICONDUCTOR DEVICES USING WEB/INTERNET PROTOCOLS 10/446359 n/a ECHO CANCELLER EMPLOYING H-REGISTER AND STORAGE REGISTER 10/355181 n/a CHEAP LIGHTPIPE DESIGN AND CONSTRUCTION 10/696734 n/a CALL REDIRECTION ZONES FOR WIRELESS COMMUNICATIONS 10/448155 n/a LINE ECHO CANCELLATION SYSTEM 10/371410 n/a AUTOMATED VOICE AND TEXT LANGUAGE TRANSLATION SYSTEM 10/638416 n/a PRIVACY AND SECURITY MECHANISM FOR PRESENCE SYSTEMS WITH TUPLE SPACES 10/375439 n/a BIMODAL FEATURE ACCESS FOR WEB APPLICATIONS 10/631789 n/a MAKING PRESENCE SERVICES AWARE OF COMMUNICATION SERVICES 10/460449 n/a 7 KHZ AUDIO EARPIECES(LOW LEAK CONDITIONS AND HIGH LEAK CONDITIONS)FOR WIDEBAND AUDIO TELEPHONE HANDSETS, CELL PHONE HANDSETS OR HEADSETS 10/631794 n/a ROLE-BASED PRESENCE 10/669138 n/a ASYMMETRICAL LOUDSPEAKER ENCLOSURES TO ACHIEVE ENCHANCED LOW FREQUENCY RESPONSE 10/680345 n/a INTERACTIVE CONFLICT RESOLUTION FOR PERSONALIZED POLICY-BASED SERVICES 10/732283 n/a METHOD FOR BROADBAND CONSTANT DIRECTIVITY BEAMFORMING FOR NON LINEAR AND NON AXI-SYMMETRIC SENSORS ARRAYS EMBEDDED IN AN OBSTACLE
Patent No. [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] ***CONFIDENTIAL TREATMENT REQUESTED
